These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991 [Abstract] [Full Text] [Related]
3. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS. Radiology; 2012 Mar 01; 262(3):1022-33. PubMed ID: 22357902 [Abstract] [Full Text] [Related]
4. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Radiology; 2009 Sep 01; 252(3):905-13. PubMed ID: 19567647 [Abstract] [Full Text] [Related]
5. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience]. Lin JJ, Wu W, Jiang XF, Jin XJ, Lu LJ, Bao LW. Zhonghua Zhong Liu Za Zhi; 2013 Feb 01; 35(2):144-7. PubMed ID: 23714672 [Abstract] [Full Text] [Related]
6. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Luo J, Peng ZW, Guo RP, Zhang YQ, Li JQ, Chen MS, Shi M. Radiology; 2011 Apr 01; 259(1):286-95. PubMed ID: 21330557 [Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, Zhang YQ, Lau WY. Radiology; 2007 Aug 01; 244(2):599-607. PubMed ID: 17641378 [Abstract] [Full Text] [Related]
8. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY. Eur J Surg Oncol; 2010 Mar 01; 36(3):257-63. PubMed ID: 19643561 [Abstract] [Full Text] [Related]
9. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Jin CB, Xie FL, Su HB. Radiology; 2005 May 01; 235(2):659-67. PubMed ID: 15858105 [Abstract] [Full Text] [Related]
10. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP. Zhonghua Yi Xue Za Zhi; 2011 Aug 23; 91(31):2190-4. PubMed ID: 22094036 [Abstract] [Full Text] [Related]
11. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH. Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768 [Abstract] [Full Text] [Related]
12. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Okuwaki Y, Nakazawa T, Kokubu S, Hidaka H, Tanaka Y, Takada J, Watanabe M, Shibuya A, Minamino T, Saigenji K. Am J Gastroenterol; 2009 Nov 10; 104(11):2747-53. PubMed ID: 19603009 [Abstract] [Full Text] [Related]
16. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K. Oncol Rep; 2004 Jan 10; 11(1):105-9. PubMed ID: 14654911 [Abstract] [Full Text] [Related]
17. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH. Surgery; 2012 May 10; 151(5):700-9. PubMed ID: 22284764 [Abstract] [Full Text] [Related]
18. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. Korean J Hepatol; 2009 Dec 10; 15(4):474-85. PubMed ID: 20037266 [Abstract] [Full Text] [Related]
19. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors. Zu QQ, Liu S, Zhou CG, Yang ZQ, Xia JG, Zhao LB, Shi HB. AJR Am J Roentgenol; 2015 Jun 10; 204(6):1322-8. PubMed ID: 26001244 [Abstract] [Full Text] [Related]
20. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M. J Immunother; 2013 Jun 10; 36(5):287-93. PubMed ID: 23719239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]